131 related articles for article (PubMed ID: 24628241)
21. Rafting through traffic: Membrane domains in cellular logistics.
Diaz-Rohrer B; Levental KR; Levental I
Biochim Biophys Acta; 2014 Dec; 1838(12):3003-3013. PubMed ID: 25130318
[TBL] [Abstract][Full Text] [Related]
22. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
23. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells.
Melo-Lima S; Lopes MC; Mollinedo F
Pharmacol Res; 2015; 95-96():2-11. PubMed ID: 25749008
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of ether lipids: natural compounds and analogues.
Gomes MAGB; Bauduin A; Le Roux C; Fouinneteau R; Berthe W; Berchel M; Couthon H; Jaffrès PA
Beilstein J Org Chem; 2023; 19():1299-1369. PubMed ID: 37701305
[TBL] [Abstract][Full Text] [Related]
25. Function and characteristics of TIM‑4 in immune regulation and disease (Review).
Wang Z; Chen C; Su Y; Ke N
Int J Mol Med; 2023 Feb; 51(2):. PubMed ID: 36524355
[TBL] [Abstract][Full Text] [Related]
26. The lipid rafts in cancer stem cell: a target to eradicate cancer.
Zhang S; Zhu N; Li HF; Gu J; Zhang CJ; Liao DF; Qin L
Stem Cell Res Ther; 2022 Aug; 13(1):432. PubMed ID: 36042526
[TBL] [Abstract][Full Text] [Related]
27. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.
Mollinedo F; Gajate C
Biochem Soc Trans; 2022 Jun; 50(3):1105-1118. PubMed ID: 35587168
[TBL] [Abstract][Full Text] [Related]
28. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis.
Li B; Qin Y; Yu X; Xu X; Yu W
Cell Prolif; 2022 Jan; 55(1):e13167. PubMed ID: 34939255
[TBL] [Abstract][Full Text] [Related]
29. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition.
Gajate C; Gayet O; Fraunhoffer NA; Iovanna J; Dusetti N; Mollinedo F
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885233
[TBL] [Abstract][Full Text] [Related]
30. Defueling the cancer: ATP synthase as an emerging target in cancer therapy.
Wang T; Ma F; Qian HL
Mol Ther Oncolytics; 2021 Dec; 23():82-95. PubMed ID: 34703878
[TBL] [Abstract][Full Text] [Related]
31. Adaptive Membrane Fluidity Modulation: A Feedback Regulated Homeostatic System Hiding in Plain Sight.
Izbicka E; Streeper RT
In Vivo; 2021; 35(6):2991-3000. PubMed ID: 34697130
[TBL] [Abstract][Full Text] [Related]
32. A functional genomic screen in Saccharomyces cerevisiae reveals divergent mechanisms of resistance to different alkylphosphocholine chemotherapeutic agents.
Garcia JM; Schwabe MJ; Voelker DR; Riekhof WR
G3 (Bethesda); 2021 Sep; 11(10):. PubMed ID: 34568930
[TBL] [Abstract][Full Text] [Related]
33. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer.
Mollinedo F; Gajate C
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439330
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine.
Mollinedo F; Gajate C
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065546
[TBL] [Abstract][Full Text] [Related]
35. Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model.
Saraiva SM; Gutiérrez-Lovera C; Martínez-Val J; Lores S; Bouzo BL; Díez-Villares S; Alijas S; Pensado-López A; Vázquez-Ríos AJ; Sánchez L; de la Fuente M
Sci Rep; 2021 May; 11(1):9873. PubMed ID: 33972572
[TBL] [Abstract][Full Text] [Related]
36. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
Vona R; Iessi E; Matarrese P
Front Cell Dev Biol; 2021; 9():622908. PubMed ID: 33816471
[TBL] [Abstract][Full Text] [Related]
37. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
Mollinedo F; Gajate C
J Lipid Res; 2020 May; 61(5):611-635. PubMed ID: 33715811
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.
Codini M; Garcia-Gil M; Albi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450869
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma.
Yang P; Zhang L; Wang T; Liu Q; Wang J; Wang Y; Tu Z; Lin F
Onco Targets Ther; 2020; 13():8055-8067. PubMed ID: 32884291
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.
Rodríguez-Nogales C; Moreno H; Zandueta C; Desmaële D; Lecanda F; Couvreur P; Blanco-Prieto MJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
